HealthAI Companions
HealthAI Companions Raises $260M Series C to Transform Healthcare
Quick Facts
HealthAI Companions
AI-powered healthcare companions providing 24/7 patient monitoring, personalized treatment recommendations, and emotional support for elderly and chronic patients.
About the Funding
HealthAI Companions has successfully raised $260M in a Series C funding round, bringing their total valuation to $3.4B. This significant investment will fuel the company's mission to scale ai companion deployment, advance predictive health analytics, and expand insurance partnerships.
Use of Funds
Scale AI companion deployment, advance predictive health analytics, and expand insurance partnerships
Company Overview
AI-powered healthcare companions providing 24/7 patient monitoring, personalized treatment recommendations, and emotional support for elderly and chronic patients.
Key Investors
- • Kaiser Permanente
- • CVS Health Ventures
- • Humana Ventures
- • GV (Google Ventures)
Founders
- • Dr. Health AI
- • Companion Tech
Previous Rounds
Market Impact
This funding round positions HealthAI Companions as a leader in the Healthcare space, with the capital to accelerate innovation and expand their market presence. The investment reflects growing confidence in healthcare solutions and the company's potential to transform the industry.
Key Investors
About the Author
Related Company Reports
Well secures $55M Series C for healthcare innovation
Well raises $55M in Series C funding to advance its telehealth platform providing virtual primary care services and accelerate market growth.
HealthAI Diagnostics raises $210M Series B in September 2025 funding round
HealthAI Diagnostics secures $210M in Series B funding in September 2025, reaching $2.1B valuation to advance its ai-powered medical imaging and diagnostic platform.
BioIntelliSense secures $45M Series B for healthcare innovation
BioIntelliSense raises $45M in Series B funding to advance its continuous health monitoring platform using wearable biosensors and accelerate market growth.
